MRNA is expected to report earnings to fall 41.12% to -115 cents per share on October 29
Q3'26
Est.
$-1.16
Q2'26
Beat
by $0.06
Q1'26
Missed
by $1.38
Q4'25
Beat
by $0.51
Q3'25
Beat
by $1.54
The last earnings report on July 31 showed earnings per share of -197 cents, beating the estimate of -202 cents. With 5.41M shares outstanding, the current market capitalization sits at 58.56B.